Cargando…
Plasma‐derived factor X concentrate compassionate use for hereditary factor X deficiency: Long‐term safety and efficacy in a retrospective data‐collection study
BACKGROUND: Coagadex is a high‐purity plasma‐derived factor X concentrate (pdFX) developed to treat hereditary factor X deficiency (FXD). OBJECTIVE: Evaluate the efficacy and safety of pdFX administered to patients with hereditary FXD. METHODS: This was an open‐label, multicenter, retrospective anal...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268662/ https://www.ncbi.nlm.nih.gov/pubmed/34263102 http://dx.doi.org/10.1002/rth2.12550 |